Pacira BioSciences, Inc. (PCRX)
Net profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -99,560 | -90,731 | 63,593 | 70,470 | 41,955 | 6,983 | -4,568 | -10,455 | 15,909 | 20,882 | 39,235 | 38,440 | 41,981 | 61,624 | 174,083 | 147,733 | 145,523 | 126,121 | -10,085 | -86 |
| Revenue (ttm) | US$ in thousands | 700,966 | 694,957 | 690,310 | 681,754 | 674,978 | 665,689 | 669,229 | 669,173 | 666,823 | 654,062 | 614,318 | 580,497 | 541,533 | 510,887 | 500,649 | 440,564 | 427,221 | 421,097 | 408,298 | 435,397 |
| Net profit margin | -14.20% | -13.06% | 9.21% | 10.34% | 6.22% | 1.05% | -0.68% | -1.56% | 2.39% | 3.19% | 6.39% | 6.62% | 7.75% | 12.06% | 34.77% | 33.53% | 34.06% | 29.95% | -2.47% | -0.02% |
December 31, 2024 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-99,560K ÷ $700,966K
= -14.20%
The net profit margin of Pacira BioSciences, Inc. fluctuated over the specified periods. There was a significant improvement in profitability from September 2020 to June 2021, with the net profit margin increasing from 29.95% to 34.77%. However, there was a gradual decline in profitability from June 2021 to December 2024, with the net profit margin decreasing to -14.20% as of December 31, 2024. This declining trend indicates challenges in generating profits relative to revenues during the latter half of the analyzed period. It is important for the company to closely monitor its expenses and revenue generation strategies to improve its profitability in the future.
Peer comparison
Dec 31, 2024